The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
CCR5 deficiency increases risk of symptomatic West Nile virus infection
Open accessAbstract
West Nile virus (WNV) is a reemerging pathogen that causes fatal encephalitis in several species, including mouse and human. Recently, we showed that the chemokine receptor CCR5 is critical for survival of mice infected with WNV, acting at the level of leukocyte trafficking to the brain. To test whether this receptor is also protective in man, we determined the frequency of CCR5Δ32, a defective CCR5 allele found predominantly in Caucasians, in two independent cohorts of patients, one from Arizona and the other from Colorado, who had laboratory-confirmed, symptomatic WNV infection. The distribution of CCR5Δ32 in a control population of healthy United States Caucasian random blood donors was in Hardy-Weinberg equilibrium and CCR5Δ32 homozygotes represented 1.0% of the total group (n = 1,318). In contrast, CCR5Δ32 homozygotes represented 4.2% of Caucasians in the Arizona cohort (odds ratios [OR] = 4.4 [95% confidence interval [CI], 1.6–11.8], P = 0.0013) and 8.3% of Caucasians in the Colorado cohort (OR = 9.1 [95% CI, 3.4–24.8], P < 0.0001). CCR5Δ32 homozygosity was significantly associated with fatal outcome in the Arizona cohort (OR = 13.2 [95% CI, 1.9–89.9], P = 0.03). We conclude that CCR5 mediates resistance to symptomatic WNV infection. Because CCR5 is also the major HIV coreceptor, these findings have important implications for the safety of CCR5-blocking agents under development for HIV/AIDS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Liu, R., Paxton, W. A., Choe, S., Ceradini, D., Martin, S. R., Horuk, R., MacDonald, M. E., Stuhlmann, H., Koup, R. A., & Landau, N. R. (1996) · Cell · doi:10.1016/s0092-8674(00)80110-5 · Cited by 3,074
Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease
Berger, E. A., Murphy, P. M., & Farber, J. M. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.657 · Cited by 2,180
Self-citationLanciotti, R. S., Roehrig, J. T., Deubel, V., Smith, J., Parker, M., Steele, K., Crise, B., Volpe, K. E., Crabtree, M. B., Scherret, J. H., et al. (1999) · Science · doi:10.1126/science.286.5448.2333 · Cited by 1,593
A Neurotropic Virus Isolated from the Blood of a Native of Uganda
Smithburn, K. C., Hughes, T. P., Burke, A. W., & Paul, J. H. (1940) · The American Journal of Tropical Medicine · doi:10.4269/ajtmh.1940.s1-20.471 · Cited by 1,112
West Nile Fever–a Reemerging Mosquito-Borne Viral Disease in Europe
Hubálek, Z., & Halouzka, J. (1999) · Emerging Infectious Diseases · doi:10.3201/eid0505.990505 · Cited by 1,063
West Nile encephalitis epidemic in southeastern Romania
Tsai, T., Popovici, F., Cernescu, C., Campbell, G., & Nedelcu, N. (1998) · The Lancet · doi:10.1016/s0140-6736(98)03538-7 · Cited by 756
THE IMMUNOGENETICS OF HUMAN INFECTIOUS DISEASES
Hill, A. V. S. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.593 · Cited by 581
Global distribution of the CCR5 gene 32-basepair deletion
Martinson, J. J., Chapman, N. H., Rees, D. C., Liu, Y.-T., & Clegg, J. B. (1997) · Nature Genetics · doi:10.1038/ng0597-100 · Cited by 539
Zimmerman, P. A., Buckler-White, A., Alkhatib, G., Spalding, T., Kubofcik, J., Combadiere, C., Weissman, D., Cohen, O., Rubbert, A., Lam, G., et al. (1997) · Molecular Medicine · doi:10.1007/bf03401665 · Cited by 416
Self-citationGlass, W. G., Lim, J. K., Cholera, R., Pletnev, A. G., Gao, J.-L., & Murphy, P. M. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042530 · Cited by 391
Self-citation
Cited by
A guide to chemokines and their receptors
Hughes, C. E., & Nibbs, R. J. B. (2018) · The FEBS Journal · doi:10.1111/febs.14466 · Cited by 1,412
Bachelerie, F., Ben-Baruch, A., Burkhardt, A. M., Combadiere, C., Farber, J. M., Graham, G. J., Horuk, R., Sparre-Ulrich, A. H., Locati, M., Luster, A. D., et al. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.007724 · Cited by 850
Self-citationGould, E., & Solomon, T. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60238-x · Cited by 818
Maraviroc for Previously Treated Patients with R5 HIV-1 Infection
Gulick, R. M., Lalezari, J., Goodrich, J., Clumeck, N., DeJesus, E., Horban, A., Nadler, J., Clotet, B., Karlsson, A., Wohlfeiler, M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0803152 · Cited by 752
Holt, N., Wang, J., Kim, K., Friedman, G., Wang, X., Taupin, V., Crooks, G. M., Kohn, D. B., Gregory, P. D., Holmes, M. C., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1663 · Cited by 677
Monath, T. P., & Vasconcelos, P. F. C. (2015) · Journal of Clinical Virology · doi:10.1016/j.jcv.2014.08.030 · Cited by 669
Kaiser, R. (2008) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2008.03.013 · Cited by 663
Shi, C., Jia, T., Mendez-Ferrer, S., Hohl, T. M., Serbina, N. V., Lipuma, L., Leiner, I., Li, M. O., Frenette, P. S., & Pamer, E. G. (2011) · Immunity · doi:10.1016/j.immuni.2011.02.016 · Cited by 506
Monath, T. P. (2005) · Expert Review of Vaccines · doi:10.1586/14760584.4.4.553 · Cited by 467
Antiretroviral therapy and management of HIV infection
Volberding, P. A., & Deeks, S. G. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60676-9 · Cited by 449
West Nile virus neuroinvasive disease
Davis, L. E., DeBiasi, R., Goade, D. E., Haaland, K. Y., Harrington, J. A., Harnar, J. B., Pergam, S. A., King, M. K., DeMasters, B. K., & Tyler, K. L. (2006) · Annals of Neurology · doi:10.1002/ana.20959 · Cited by 388
Targeting CCL5 in inflammation
Marques, R. E., Guabiraba, R., Russo, R. C., & Teixeira, M. M. (2013) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2013.837886 · Cited by 384
Replication cycle of chikungunya: A re-emerging arbovirus
Solignat, M., Gay, B., Higgs, S., Briant, L., & Devaux, C. (2009) · Virology · doi:10.1016/j.virol.2009.07.024 · Cited by 384
West Nile Virus: Biology, Transmission, and Human Infection
Colpitts, T. M., Conway, M. J., Montgomery, R. R., & Fikrig, E. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.00045-12 · Cited by 382
Getts, D. R., Terry, R. L., Getts, M. T., Müller, M., Rana, S., Shrestha, B., Radford, J., Van Rooijen, N., Campbell, I. L., & King, N. J. C. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080421 · Cited by 360
Samuel, M. A., & Diamond, M. S. (2006) · Journal of Virology · doi:10.1128/jvi.01122-06 · Cited by 352
Genome-wide scans for footprints of natural selection
Oleksyk, T. K., Smith, M. W., & O'Brien, S. J. (2010) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2009.0219 · Cited by 340
A genome-wide CRISPR screen identifies a restricted set of HIV host dependency factors
Park, R. J., Wang, T., Koundakjian, D., Hultquist, J. F., Lamothe-Molina, P., Monel, B., Schumann, K., Yu, H., Krupzcak, K. M., Garcia-Beltran, W., et al. (2017) · Nature Genetics · doi:10.1038/ng.3741 · Cited by 333
Chemokines and leukocyte traffic
Sallusto, F., & Baggiolini, M. (2008) · Nature Immunology · doi:10.1038/ni.f.214 · Cited by 325
HIV drug development: the next 25 years
Flexner, C. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2336 · Cited by 317
Esté, J. A., & Telenti, A. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61052-6 · Cited by 287
The growth and potential of human antiviral monoclonal antibody therapeutics
Marasco, W. A., & Sui, J. (2007) · Nature Biotechnology · doi:10.1038/nbt1363 · Cited by 284
T cell responses in the central nervous system
Korn, T., & Kallies, A. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2016.144 · Cited by 268
Biology of CCR5 and Its Role in HIV Infection and Treatment
Lederman, M. M., Penn-Nicholson, A., Cho, M., & Mosier, D. (2006) · JAMA · doi:10.1001/jama.296.7.815 · Cited by 266
Gene Insertion Into Genomic Safe Harbors for Human Gene Therapy
Papapetrou, E. P., & Schambach, A. (2016) · Molecular Therapy · doi:10.1038/mt.2016.38 · Cited by 238
Lim, J. K., Obara, C. J., Rivollier, A., Pletnev, A. G., Kelsall, B. L., & Murphy, P. M. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003003 · Cited by 176
Self-citationHultquist, J. F., Schumann, K., Woo, J. M., Manganaro, L., McGregor, M. J., Doudna, J., Simon, V., Krogan, N. J., & Marson, A. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.09.080 · Cited by 170
Li, X.-F., Dong, H.-L., Wang, H.-J., Huang, X.-Y., Qiu, Y.-F., Ji, X., Ye, Q., Li, C., Liu, Y., Deng, Y.-Q., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-02975-w · Cited by 94
Hofer, U., Henley, J. E., Exline, C. M., Mulhern, O., Lopez, E., & Cannon, P. M. (2013) · Journal of Infectious Diseases · doi:10.1093/infdis/jit382 · Cited by 43
“Furthermore, CCR5-negative individuals are highly resistant to HIV-1 [5], while exhibiting minimal negative side effects [6, 7].”
BackgroundLarena, M., Regner, M., & Lobigs, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044834 · Cited by 38
Hanley, K. A., & Weaver, S. C. (2008) · Origin and Evolution of Viruses · doi:10.1016/b978-0-12-374153-0.00016-3 · Cited by 28
Onisiforou, A., & Spyrou, G. M. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab141 · Cited by 23
Metadata
- Authors
- Glass, W. G., McDermott, D. H., Lim, J. K., Lekhong, S., Yu, S. F., Frank, W. A., Pape, J., Cheshier, R. C., & Murphy, P. M.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2006-01-17
- Volume
- 203
- Issue
- 1
- Pages
- 35-40
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2009998721
- Cited by
- 519
- References
- 19
- FWCI
- 47.54
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.